Julian Teare

Julian Teare

Imperial College London

H-index: 38

Europe-United Kingdom

About Julian Teare

Julian Teare, With an exceptional h-index of 38 and a recent h-index of 25 (since 2020), a distinguished researcher at Imperial College London, specializes in the field of Gastroenterology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib

181 ENDOBARRIER®, A DUODENAL-JEJUNAL BYPASS LINER DEVICE, ALTERS THE GLOBAL METABOLIC AND THE GUT BACTERIAL PROFILES OF PATIENTS WITH OBESITY AND DIABETES

Sa1871 NETWORKS OF PATHOBIONTS IN THE TUMOUR MUCOSAL NICHE PREDICT SURVIVAL FOLLOWING COLORECTAL CANCER RESECTION

Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide

P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK …

Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and omicron variants in inflammatory bowel disease patients after 3 doses of …

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

Neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine …

Julian Teare Information

University

Position

Professor of Gastroenterology

Citations(all)

7704

Citations(since 2020)

3548

Cited By

5351

hIndex(all)

38

hIndex(since 2020)

25

i10Index(all)

81

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Julian Teare Skills & Research Interests

Gastroenterology

Top articles of Julian Teare

Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib

Journal of Crohn's and Colitis

2023/11/6

181 ENDOBARRIER®, A DUODENAL-JEJUNAL BYPASS LINER DEVICE, ALTERS THE GLOBAL METABOLIC AND THE GUT BACTERIAL PROFILES OF PATIENTS WITH OBESITY AND DIABETES

Gastroenterology

2023/5/1

Sa1871 NETWORKS OF PATHOBIONTS IN THE TUMOUR MUCOSAL NICHE PREDICT SURVIVAL FOLLOWING COLORECTAL CANCER RESECTION

Gastroenterology

2023/5/1

Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide

Diabetes Care

2023/4/1

P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK …

Journal of Crohn's and Colitis

2023/2/1

Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and omicron variants in inflammatory bowel disease patients after 3 doses of …

Gastroenterology

2023/2/1

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

EBioMedicine

2023/2/1

Neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine …

Eclinicalmedicine

2023/10/1

1708-P: Comparing 9-vs. 12-Month Implantation in the Worldwide EndoBarrier (EB) Registry

Diabetes

2023/6/20

Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer

Microbiome

2023/5/8

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre …

The Lancet Gastroenterology & Hepatology

2022/11/1

P2 COVID-19 vaccination response in immunosuppressed patients with IBD is associated with altered gut microbiota function

2022/6/1

1415-P: Risk–Benefit Data from the Worldwide EndoBarrier (EB) Registry

Diabetes

2022/6/1

Does bypass of the proximal small intestine impact food intake, preference, and taste function in humans? An experimental medicine study using the duodenal-jejunal bypass liner

Nutrients

2022/5/20

Su1611: POOR RESPONSE TO ANTI-SARS-COV-2 VACCINATION IN IMMUNOSUPPRESSED INFLAMMATORY BOWEL DISEASE PATIENTS IS ASSOCIATED WITH ALTERED GUT MICROBIOTA FUNCTION

Gastroenterology

2022/5

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

The lancet Gastroenterology & hepatology

2022/4/1

Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis

Journal for Immunotherapy of Cancer

2022

A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose: mannitol ratio in coeliac and Crohn’s disease

BMC gastroenterology

2022/12

Julian Teare
Julian Teare

H-Index: 22

Hutan Ashrafian
Hutan Ashrafian

H-Index: 41

See List of Professors in Julian Teare University(Imperial College London)